HEADER ANTIVIRAL PROTEIN/IMMUNE SYSTEM 07-OCT-11 2LK9 TITLE STRUCTURE OF BST-2/TETHERIN TRANSMEMBRANE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BONE MARROW STROMAL ANTIGEN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HELICAL SIGNAL-ANCHOR FOR TYPE II MEMBRANE PROTEIN REGION COMPND 5 RESIDUES 22-45; COMPND 6 SYNONYM: BST-2, HM1.24 ANTIGEN, TETHERIN; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BST2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET31B(+) KEYWDS MEMBRANE, MICELLE, ANTIVIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA SOLUTION NMR AUTHOR M.SKASKO,Y.WANG,Y.TIAN,A.TOKAREV,J.MUNGUIA,A.RUIZ,E.STEPHENS, AUTHOR 2 S.OPELLA,J.GUATELLI REVDAT 2 18-JAN-12 2LK9 1 JRNL REVDAT 1 09-NOV-11 2LK9 0 JRNL AUTH M.SKASKO,Y.WANG,Y.TIAN,A.TOKAREV,J.MUNGUIA,A.RUIZ, JRNL AUTH 2 E.B.STEPHENS,S.J.OPELLA,J.GUATELLI JRNL TITL HIV-1 VPU PROTEIN ANTAGONIZES INNATE RESTRICTION FACTOR JRNL TITL 2 BST-2 VIA LIPID-EMBEDDED HELIX-HELIX INTERACTIONS. JRNL REF J.BIOL.CHEM. V. 287 58 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22072710 JRNL DOI 10.1074/JBC.M111.296772 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-11. REMARK 100 THE RCSB ID CODE IS RCSB102484. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 15N] BST, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR_NIH, NMRPIPE, NMRVIEW REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 RES C SSSEQI REMARK 465 LYS A 18 REMARK 465 ARG A 19 REMARK 465 SER A 20 REMARK 465 LYS A 21 REMARK 465 ILE A 46 REMARK 465 LYS A 47 REMARK 465 LYS A 48 REMARK 465 LYS A 49 REMARK 465 LYS A 50 REMARK 465 LYS A 51 REMARK 465 LYS A 52 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 RES CSSEQI ATOMS REMARK 470 LEU A 22 CB CG CD1 CD2 REMARK 470 LEU A 23 CB CG CD1 CD2 REMARK 470 LEU A 24 CB CG CD1 CD2 REMARK 470 ILE A 26 CB CG1 CG2 CD1 REMARK 470 ILE A 28 CB CG1 CG2 CD1 REMARK 470 LEU A 29 CB CG CD1 CD2 REMARK 470 VAL A 30 CB CG1 CG2 REMARK 470 LEU A 31 CB CG CD1 CD2 REMARK 470 LEU A 32 CB CG CD1 CD2 REMARK 470 ILE A 33 CB CG1 CG2 CD1 REMARK 470 ILE A 34 CB CG1 CG2 CD1 REMARK 470 VAL A 35 CB CG1 CG2 REMARK 470 ILE A 36 CB CG1 CG2 CD1 REMARK 470 LEU A 37 CB CG CD1 CD2 REMARK 470 VAL A 39 CB CG1 CG2 REMARK 470 PRO A 40 CB CG CD REMARK 470 LEU A 41 CB CG CD1 CD2 REMARK 470 ILE A 42 CB CG1 CG2 CD1 REMARK 470 ILE A 43 CB CG1 CG2 CD1 REMARK 470 PHE A 44 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR A 45 CB OG1 CG2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17985 RELATED DB: BMRB DBREF 2LK9 A 18 47 UNP Q10589 BST2_HUMAN 18 47 SEQADV 2LK9 SER A 20 UNP Q10589 CYS 20 ENGINEERED MUTATION SEQADV 2LK9 LYS A 48 UNP Q10589 EXPRESSION TAG SEQADV 2LK9 LYS A 49 UNP Q10589 EXPRESSION TAG SEQADV 2LK9 LYS A 50 UNP Q10589 EXPRESSION TAG SEQADV 2LK9 LYS A 51 UNP Q10589 EXPRESSION TAG SEQADV 2LK9 LYS A 52 UNP Q10589 EXPRESSION TAG SEQRES 1 A 35 LYS ARG SER LYS LEU LEU LEU GLY ILE GLY ILE LEU VAL SEQRES 2 A 35 LEU LEU ILE ILE VAL ILE LEU GLY VAL PRO LEU ILE ILE SEQRES 3 A 35 PHE THR ILE LYS LYS LYS LYS LYS LYS HELIX 1 1 LEU A 22 THR A 45 1 24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 110 0 0 1 0 0 0 6 0 0 0 3 END